Adenoma Detection Rate Using AI System in China
Launched by CHANGHAI HOSPITAL · Feb 12, 2019
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
Colorectal cancer is common in China. Most colorectal cancers happen when an adenoma becomes cancerous. Doctors use colonoscopy to look inside the colon and rectum and find adenomas and remove them. Removing adenomas is known to reduce the chances of a person developing colorectal cancers. The ability of colonoscopists finding adenomas varies, and there is a lot of researches into how to improve "adenoma detection rates".
A new AI system, called the CSK endoscopic diagnosis and treatment system has been designed to improve the rate of polyp detection at colonoscopy. Previous tests have sho...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients referred for screening, surveillance, or diagnostic colonoscopy
- • All patients must be able to give informed consent
- Exclusion Criteria:
- • Patients with any absolute contraindications to colonoscopy
- • Patients with established or suspicion of large bowel obstruction or pseudo-obstruction
- • Patients with known colon cancer or polyposis syndromes
- • Patients with known colonic strictures
- • Patients with known severe diverticular segments (that is likely to impede colonoscope passage)
- • Patients with active colitis (ulcerative colitis, Crohn's colitis, diverticulitis, infective colitis)
- • Patients lacking capacity to give informed consent
- • Pregnancy
- • Patients who are on clopidogrel, warfarin, or other new generation anticoagulants who have not stopped this for the procedure.
- • Patients who are attending for a therapeutic procedure or assessment of a known lesion
About Changhai Hospital
Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Tianjin, Tianjin, China
Guangzhou, Guangdong, China
Tianjin, Tianjin, China
Patients applied
Trial Officials
En-Da YU, MD
Principal Investigator
Changhai Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials